
- Volume 0 0
Xenical
Roche (Nutley, NJ) recently announcedthat the FDA has approved labeling foruse of the prescription weight-loss medicationXenical (orlistat) in the managementof obese adolescents aged 12 to 16years. This approval offers physicians andparents of overweight and obese adolescentsa safe and effective treatment optionto help manage their weight. Xenicalworks locally in the stomach to preventdietary fat absorption by approximately30%. It helps the patient lose weight aswell as maintain the weight loss. For moreinformation, visit www.xenical.com.
Articles in this issue
over 21 years ago
Interface Speeds Up Prescription Fillingover 21 years ago
New Technologies Top Surveyover 21 years ago
Partnership Addresses Packaging Solutionsover 21 years ago
PDX Software Gets High Marksover 21 years ago
Polar Powder Cold Pak with Magnetic Therapyover 21 years ago
Seal•ONover 21 years ago
SaltAire Sinus Reliefover 21 years ago
Zim's Crack Creme Hand Sanitizerover 21 years ago
CoroWise Plant Sterolsover 21 years ago
CulturelleNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































